Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 57 | 51 | −6 |
| Shares | 27.3M | 26.6M | −712.9K (−2.6%) |
| Value | $13.6M | $12.6M | −$991.9K (−7.3%) |
New holders (2)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Modera Wealth Management, LLC | 94,500 | $44.4K | 0.00% |
| Sawtooth Solutions, LLC | 60,016 | $28.2K | 0.00% |
Sold out (8)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Virtu Financial LLC | 144,095 | $72.0K |
| HRT Financial LP | 54,567 | $27.0K |
| Citadel Advisors LLC | 52,106 | $26.1K |
| ExodusPoint Capital Management, LP | 46,023 | $23.0K |
| Goldman Sachs Group Inc | 35,203 | $17.6K |
| Victory Capital Management Inc | 23,628 | $11.8K |
| UBS Group AG | 11,852 | $5.93K |
| Citigroup Inc | 180 | $90 |